JP2009508511A - ヒト平滑筋細胞の獲得方法およびヒト平滑筋細胞の適用 - Google Patents

ヒト平滑筋細胞の獲得方法およびヒト平滑筋細胞の適用 Download PDF

Info

Publication number
JP2009508511A
JP2009508511A JP2008531733A JP2008531733A JP2009508511A JP 2009508511 A JP2009508511 A JP 2009508511A JP 2008531733 A JP2008531733 A JP 2008531733A JP 2008531733 A JP2008531733 A JP 2008531733A JP 2009508511 A JP2009508511 A JP 2009508511A
Authority
JP
Japan
Prior art keywords
cells
medium
cell
human
hcms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008531733A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009508511A5 (https=
Inventor
ル・リクース、ソフィー
ラカサーニュ、マリー−ノエル
マロロー、ジャン−ピエール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
IVS Institut des Vaisseaux et du Sang
Original Assignee
Assistance Publique Hopitaux de Paris APHP
IVS Institut des Vaisseaux et du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP, IVS Institut des Vaisseaux et du Sang filed Critical Assistance Publique Hopitaux de Paris APHP
Publication of JP2009508511A publication Critical patent/JP2009508511A/ja
Publication of JP2009508511A5 publication Critical patent/JP2009508511A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0661—Smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1323—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from skeletal muscle cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
JP2008531733A 2005-09-19 2006-09-19 ヒト平滑筋細胞の獲得方法およびヒト平滑筋細胞の適用 Pending JP2009508511A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0509557A FR2890977A1 (fr) 2005-09-19 2005-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications
PCT/FR2006/002144 WO2007034069A1 (fr) 2005-09-19 2006-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications

Publications (2)

Publication Number Publication Date
JP2009508511A true JP2009508511A (ja) 2009-03-05
JP2009508511A5 JP2009508511A5 (https=) 2012-10-04

Family

ID=36587333

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008531733A Pending JP2009508511A (ja) 2005-09-19 2006-09-19 ヒト平滑筋細胞の獲得方法およびヒト平滑筋細胞の適用

Country Status (10)

Country Link
US (1) US20090269310A1 (https=)
EP (1) EP1934333B9 (https=)
JP (1) JP2009508511A (https=)
CN (1) CN101310013B (https=)
AT (1) ATE531791T1 (https=)
AU (1) AU2006293814B2 (https=)
CA (1) CA2622916A1 (https=)
FR (1) FR2890977A1 (https=)
IL (1) IL190289A0 (https=)
WO (1) WO2007034069A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022526229A (ja) * 2019-03-22 2022-05-24 インノヴァセル アーゲー 誘導平滑筋細胞を得るための方法
WO2024143453A1 (ja) * 2022-12-28 2024-07-04 インターステム株式会社 細胞組成物

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909559B1 (fr) * 2006-12-06 2012-09-07 Inst Vaisseaux Et Du Sang Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
ES2689932T3 (es) * 2008-11-04 2018-11-16 Inregen Construcciones de armazones de células
US11617768B2 (en) * 2017-12-14 2023-04-04 Innovacell Ag Methods for obtaining muscle derived cells
CN112119155A (zh) * 2018-05-08 2020-12-22 苏黎士大学 用于无异种产生hMPC群的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003535586A (ja) * 2000-06-07 2003-12-02 アシスタンス ピュブリク−オピトー ドゥ パリ 筋組織由来の特徴づけされた細胞集団の獲得プロセス及びその利用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040247575A1 (en) * 2003-06-03 2004-12-09 Caplice Noel M. Smooth muscle progenitor cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003535586A (ja) * 2000-06-07 2003-12-02 アシスタンス ピュブリク−オピトー ドゥ パリ 筋組織由来の特徴づけされた細胞集団の獲得プロセス及びその利用

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JPN6012014765; Ｃａｒｄｉｏｖａｓｃｕｌａｒ　Ｒｅｓ． Ｖｏｌ．６２, 2004, ｐ．１７６-１８４ *
JPN6012014766; 実験医学 Ｖｏｌ．１８，　Ｎｏ．５, 2000, ｐ．１３８-１４４ *
JPN6012014767; Ｃｏｎｎｅｃｔｉｖｅ　Ｔｉｓｓｕｅ Ｖｏｌ．３４, 2002, ｐ．１７５-１７９ *
JPN6012014768; Ｄｅｖｅｌｏｐｍｅｎｔ Ｖｏｌ．１２７, 2000, ｐ．１６２７-１６３９ *
JPN6012014769; Ｄｅｖｅｌｏｐ．Ｂｉｏｌ． Ｖｏｌ．１７２, 1995, ｐ．４２２-４３９ *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022526229A (ja) * 2019-03-22 2022-05-24 インノヴァセル アーゲー 誘導平滑筋細胞を得るための方法
JP7616665B2 (ja) 2019-03-22 2025-01-17 インノヴァセル ゲーエムベーハー 誘導平滑筋細胞を得るための方法
JP2025011242A (ja) * 2019-03-22 2025-01-23 インノヴァセル ゲーエムベーハー 誘導平滑筋細胞を得るための方法
US12312600B2 (en) 2019-03-22 2025-05-27 Innovacell Gmbh Methods for obtaining induced smooth muscle cells
WO2024143453A1 (ja) * 2022-12-28 2024-07-04 インターステム株式会社 細胞組成物

Also Published As

Publication number Publication date
US20090269310A1 (en) 2009-10-29
FR2890977A1 (fr) 2007-03-23
CN101310013B (zh) 2011-09-07
IL190289A0 (en) 2011-08-01
AU2006293814A1 (en) 2007-03-29
AU2006293814B2 (en) 2011-09-29
EP1934333B1 (fr) 2011-11-02
EP1934333B9 (fr) 2012-05-02
EP1934333A1 (fr) 2008-06-25
ATE531791T1 (de) 2011-11-15
CA2622916A1 (fr) 2007-03-29
WO2007034069A1 (fr) 2007-03-29
CN101310013A (zh) 2008-11-19

Similar Documents

Publication Publication Date Title
Wang et al. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell
CN112891374B (zh) 治疗中风的影响的方法
WO2007061750A2 (en) Adipose tissue derived stromal cells for the treatment of neurological disorders
KR20150103211A (ko) 프로스타시클린 및 중간엽 줄기 세포를 사용한 혈관병증의 치료
Bossolasco et al. Skeletal muscle differentiation potential of human adult bone marrow cells
CN106727703B (zh) 治疗移植物抗宿主疾病的方法
JP2007143554A (ja) 細胞移植方法及び試薬
CN111803523A (zh) 利用间充质干细胞的肺动脉高血压的治疗
JP2023133612A (ja) 膵島移植のための改善された方法
JP2011519574A (ja) 細胞ベースの治療に関連する材料および方法
JP2011519574A5 (https=)
CN111163787A (zh) 用于靶向组织修复的血小板囊泡工程化的细胞和细胞外囊泡
EP3277297A1 (en) Methods and compositions for stimulation of cell proliferation and provision of biologically active mixtures of fgf2 isoforms
Yang et al. Nicotinamide facilitates mesenchymal stem cell differentiation into insulin-producing cells and homing to pancreas in diabetic mice
TW201000110A (en) Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells
JP2009508511A (ja) ヒト平滑筋細胞の獲得方法およびヒト平滑筋細胞の適用
JP2009508511A5 (https=)
AU2004286322A1 (en) Novel multipotent stem cells and use thereof
US20090155220A1 (en) Use of Bone-Marrow Derived Stem Cells to Treat Ischemia
US20200101117A1 (en) Methods of cardiac repair
US20050232905A1 (en) Use of peripheral blood cells for cardiac regeneration
JP4083024B6 (ja) 細胞移植方法及び試薬
WO2007138577A2 (en) Methods of generating a neural tissue using muscle-derived cells
HK1238561A1 (zh) 治疗移植物抗宿主疾病的方法
Zeng Swine bone marrow-derived multipotent adult stem cells and its application in swine hearts with postinfarction LV dysfunction

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090914

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120321

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120621

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120628

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120718

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120725

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20120820

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130319

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20131112